MAP2K7
MAP2K7 (mitogen-activated protein kinase kinase 7, also known as MKK7, Jnkk2, SAPKK4 and PRKMK7) is a dual specificity protein kinase in the MAP kinase cascade. It activates the c-Jun N-terminal kinases and transmits cellular responses to pro-inflammatory cytokines and environmental stress. Browse Assay Genie's current range of MAP2K7 research reagents below, or read on for the biology behind the target.
MAP2K7 is a dual specificity protein kinase and an essential component of the MAP kinase signal transduction pathway, in particular the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) pathway. Together with MAP2K4/MKK4, it is one of the only known kinases to directly activate MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. Both kinases phosphorylate the Thr-Pro-Tyr motif of the JNKs, but they differ in site preference: MAP2K4 favours the Tyr residue and MAP2K7 favours the Thr residue. Phosphorylation of the Thr residue alone is enough to raise JNK activity, so MAP2K7 is important for triggering JNK activation, while the additional Tyr phosphorylation by MAP2K4 gives optimal activation.
MAP2K7 has a specific role in the JNK pathway activated by pro-inflammatory cytokines. The MKK/JNK pathway is also involved in mitochondrial death signalling, including the release of cytochrome c, which leads to apoptosis. MAP2K7 itself is phosphorylated and activated by MAP kinase kinase kinases, including MAP3K1/MEKK1, MAP3K2/MEKK2, MAP3K3/MEKK5 and MAP4K2/GCK. It also forms part of a non-canonical MAPK pathway, made up of the upstream kinase MAP3K12 and the downstream kinases MAPK1/ERK2 and MAPK3/ERK1, which enhances AP-1-mediated transcription of APP in response to APOE.
The MAP2K7 gene encodes a protein of the protein kinase superfamily, belonging to the STE Ser/Thr protein kinase family and the MAP kinase kinase subfamily. It is found in the nucleus and cytoplasm, and alternative splicing produces multiple transcript variants. Orthologues are present in mouse and rat (Map2k7), which supports comparative work on stress and cytokine signalling.
MAP2K7 directly activates JNK1, JNK2 and JNK3 by phosphorylating the Thr residue of the Thr-Pro-Tyr motif, making it a key node in the SAP/JNK pathway.
MAP2K7 has a specific role in the JNK pathway activated by pro-inflammatory cytokines and mediates cell responses to environmental stress.
The MKK/JNK pathway contributes to mitochondrial death signalling, including cytochrome c release, which leads to apoptosis.
MAP2K7 is part of a pathway with MAP3K12, ERK1 and ERK2 that enhances AP-1-mediated transcription of APP in response to APOE.
MAP2K7 is a dual specificity kinase that phosphorylates and activates the JNKs (MAPK8, MAPK9 and MAPK10), preferentially at the Thr residue of the Thr-Pro-Tyr motif. It acts in stress and pro-inflammatory cytokine signalling, and in the mitochondrial death pathway leading to apoptosis.
MAP2K7 is also called MKK7, Jnkk2, SAPKK4 and PRKMK7. Its HGNC name is mitogen-activated protein kinase kinase 7, and UniProt lists it as dual specificity mitogen-activated protein kinase kinase 7. Alternative splicing gives multiple transcript variants.
Yes. Mouse and rat both have a Map2k7 orthologue. The human protein belongs to the MAP kinase kinase subfamily of the STE Ser/Thr protein kinase family. Check the datasheet of any product for its validated reactivity.
Other MAP kinase kinases and upstream MAP3K and MAP4K activators that act alongside MAP2K7 in stress and cytokine signalling.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O14733; product specifications from Assay Genie datasheets.